Fir Tree Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-173,034
Closed -$1.78M 279
2023
Q2
$1.78M Sell
173,034
-2,048
-1% -$20.9K 0.17% 187
2023
Q1
$1.77M Buy
175,082
+100,862
+136% +$1.02M 0.14% 201
2022
Q4
$742K Sell
74,220
-1,523
-2% -$15K 0.04% 304
2022
Q3
$734K Hold
75,743
0.02% 407
2022
Q2
$734K Sell
75,743
-2,034
-3% -$19.8K 0.02% 432
2022
Q1
$758K Buy
+77,777
New +$751K 0.02% 436

Fir Tree Capital Management's DALS Position: Q3 2023 in Review

Fir Tree Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 173,034 shares — an estimated $1.78M sold.

Fir Tree Capital Management first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $1.78M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Fir Tree Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Fir Tree Capital Management sold 173,034 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $1.78M.
  • Fir Tree Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 6 quarters.
  • Fir Tree Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $1.78M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Fir Tree Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.